Spots Global Cancer Trial Database for Procalcitonin in Hepatocellular Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Procalcitonin in Hepatocellular Carcinoma
Official Title: Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment
Study ID: NCT01518829
Conditions
Interventions
Study Description
Brief Summary: the value of serum procalcitonin in differentiation between bacterial infection and non infectious inflammation in febrile HCC patients following locoeregional treatment for HCC.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tropical medicine department and hepatocellular carcinoma clinic, Cairo, , Egypt
Contact Details
Name: Hisham K Dabbous, professor
Affiliation: Tropical medicine department
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
